抗凝血因子Ⅱ(F2)多克隆抗體

Anti-Coagulation Factor II (F2) Polyclonal Antibody

FII; TM; PT; Thrombin; Prothrombin; Pro-Thrombin; Activation peptide fragment 1; Activation peptide fragment 2

  • 抗凝血因子Ⅱ(F2)多克隆抗體產(chǎn)品包裝(模擬)
  • 抗凝血因子Ⅱ(F2)多克隆抗體產(chǎn)品包裝(模擬)
  • 抗凝血因子Ⅱ(F2)多克隆抗體Mouse Hepa1-6 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20μg/ml rabbit Anti-rat F2 Polyclonal Antibody (Catalog FAA820Ra01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1μg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

用法

Flow cytometry: 20μg/ml;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復(fù)凍融。

贈品

相關(guān)產(chǎn)品

編號適用物種:Rattus norvegicus (Rat,大鼠)應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPA820Ra03凝血因子Ⅱ(F2)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA820Ra02凝血因子Ⅱ(F2)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA820Ra01凝血因子Ⅱ(F2)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APA820Ra02凝血因子Ⅱ(F2)活性蛋白Cell?culture;?Activity?Assays.
PAA820Ra02凝血因子Ⅱ(F2)多克隆抗體WB; IHC; ICC; IP.
PAA820Ra03凝血因子Ⅱ(F2)多克隆抗體WB; IHC; ICC; IP.
PAA820Ra01凝血因子Ⅱ(F2)多克隆抗體WB; IHC; ICC; IP.
FAA820Ra01抗凝血因子Ⅱ(F2)多克隆抗體FCM
LAA820Ra71凝血因子Ⅱ(F2)多克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
LAA820Ra81凝血因子Ⅱ(F2)多克隆抗體(異硫氰酸熒光素標(biāo)記)WB; IHC; ICC; IF.
MAA820Ra26凝血因子Ⅱ(F2)單克隆抗體WB; IHC; ICC; IP.
MAA820Ra29凝血因子Ⅱ(F2)單克隆抗體WB; IHC
MAA820Ra21凝血因子Ⅱ(F2)單克隆抗體WB
MAA820Ra23凝血因子Ⅱ(F2)單克隆抗體WB; IHC
MAA820Ra24凝血因子Ⅱ(F2)單克隆抗體WB; IHC
MAA820Ra25凝血因子Ⅱ(F2)單克隆抗體WB; IHC
MAA820Ra27凝血因子Ⅱ(F2)單克隆抗體WB; IHC; ICC/IF
MAA820Ra22凝血因子Ⅱ(F2)單克隆抗體WB,IHC
SEA820Ra凝血因子Ⅱ(F2)檢測試劑盒(酶聯(lián)免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA820Ra凝血因子Ⅱ(F2)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
KSA820Ra01凝血因子Ⅱ(F2)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)Main materials for "Do It (ELISA Kit) Yourself".

參考文獻

雜志參考文獻
Blood Cells Mol DisUpregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients[Pubmed:35180460]